Ratio Therapeutics Inc. is a Boston-based pharmaceutical company with the mission to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company currently employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/17/24 | $50,000,000 | Series B |
Bristol Myers Squibb Cornell Center for Technology Licensing Duquesne Family Office PAGS Group Schusterman Family Interests | undisclosed |
